HMGB1 protein and linker histone H1 have overlapping binding sites in the nucleosome. HMGB1 has been implicated in many DNA-dependent processes in chromatin involving binding of specific proteins, including transcription factors, to DNA sites pre-bent by HMGB1. HMGB1 can also act as an extracellular signaling molecule by promoting inflammation, tumor growth a metastasis. Many of the intra- and extracellular functions of HMGB1 depend on redox-sensitive cysteine residues of the protein. Here we report that mild oxidization of HMGB1 (and much less mutation of cysteines involved in disulphide bond formation) can severely compromise the functioning of the protein as a DNA chaperone by inhibiting its ability to unwind or bend DNA. Histone H1 (via the highly basic C-terminal domain) significantly inhibits DNA bending by the full-length HMGB1, and the inhibition is further enhanced upon oxidization of HMGB1. Interestingly, DNA bending by HMGB1 lacking the acidic C-tail (HMGB1ΔC) is much less affected by histone H1, but oxidization rendered DNA bending by HMGB1ΔC and HMGB1 equally prone for inhibition by histone H1. Possible consequences of histone H1-mediated inhibition of DNA bending by HMGB1 of different redox state for the functioning of chromatin are discussed.

• MeSH
• cystein genetika   metabolismus   MeSH
• histony chemie   genetika   metabolismus   MeSH
• krysa rodu Rattus MeSH
• molekulární modely MeSH
• mutace MeSH
• nukleozomy MeSH
• oxidace-redukce MeSH
• protein HMGB1 chemie   genetika   metabolismus   MeSH
• superhelikální DNA metabolismus   MeSH
• vazba proteinů MeSH
• zvířata MeSH
• Check Tag
• krysa rodu Rattus MeSH
• zvířata MeSH
• Publikační typ
• časopisecké články MeSH
• práce podpořená grantem MeSH
• Názvy látek
• cystein MeSH
• Hbp1 protein, rat MeSH Prohlížeč
• histony MeSH
• nukleozomy MeSH
• protein HMGB1 MeSH
• superhelikální DNA MeSH

HMGB1 is an architectural protein in chromatin, acting also as a signaling molecule outside the cell. Recent reports from several laboratories provided evidence that a number of both the intracellular and extracellular functions of HMGB1 may depend on redox-sensitive cysteine residues of the protein. In this study we demonstrate that redox state of HMGB1 can significantly modulate the ability of the protein to bind and bend DNA, as well as to promote DNA end-joining. We also report a high affinity binding of histone H1 to hemicatenated DNA loops and DNA minicircles. Finally, we show that reduced HMGB1 can readily displace histone H1 from DNA, while oxidized HMGB1 has limited capacity for H1 displacement. Our results suggested a novel mechanism for the HMGB1-mediated modulation of histone H1 binding to DNA. Possible biological consequences of linker histones H1 replacement by HMGB1 for the functioning of chromatin are discussed.

• MeSH
• chromatin genetika   metabolismus   MeSH
• exprese genu MeSH
• genetické vektory chemie   MeSH
• histony genetika   metabolismus   MeSH
• konkatenovaná DNA genetika   metabolismus   MeSH
• kruhová DNA genetika   metabolismus   MeSH
• krysa rodu Rattus MeSH
• lidé MeSH
• oxidace-redukce MeSH
• protein HMGB1 genetika   metabolismus   MeSH
• rekombinantní proteiny genetika   metabolismus   MeSH
• skot MeSH
• vazba proteinů MeSH
• zvířata MeSH
• Check Tag
• krysa rodu Rattus MeSH
• lidé MeSH
• skot MeSH
• zvířata MeSH
• Publikační typ
• časopisecké články MeSH
• práce podpořená grantem MeSH
• Názvy látek
• chromatin MeSH
• histony MeSH
• konkatenovaná DNA MeSH
• kruhová DNA MeSH
• protein HMGB1 MeSH
• rekombinantní proteiny MeSH

Telomere repeats are added onto chromosome ends by telomerase, consisting of two main core components: a catalytic protein subunit (telomerase reverse trancriptase, TERT), and an RNA subunit (telomerase RNA, TR). Here, we report for the first time evidence that HMGB1 (a chromatin-associated protein in mammals, acting as a DNA chaperone in transcription, replication, recombination, and repair) can modulate cellular activity of mammalian telomerase. Knockout of the HMGB1 gene (HMGB1 KO) in mouse embryonic fibroblasts (MEFs) results in chromosomal abnormalities, enhanced colocalization of γ-H2AX foci at telomeres, and a moderate shortening of telomere lengths. HMGB1 KO MEFs also exhibit significantly (>5-fold) lower telomerase activity than the wild-type MEFs. Correspondingly, enhanced telomerase activity is observed upon overexpression of HMGB1 in MEFs. HMGB1 physically interacts with both TERT and TR, as well as with active telomerase complex in vitro. However, direct interaction of HMGB1 with telomerase is most likely not accountable for the observed higher telomerase activity in HMGB1-containing cells, as revealed from the inability of purified HMGB1 protein to stimulate telomerase activity in vitro. While no transcriptional silencing of TERT is observed in HMGB1 KO MEFs, levels of TR are diminished (~3-fold), providing possible explanation for the observed lower telomerase activity in HMGB1 KO cells. Interestingly, knockout of the HMGB2 gene elevates telomerase activity (~3-fold) in MEFs, suggesting that the two closely related proteins of the HMGB family, HMGB1 and HMGB2, have opposite effects on telomerase activity in the cell. The ability of HMGB1 to modulate cellular activity of telomerase and to maintain telomere integrity can help to understand some aspects of the protein involvement in chromosome stability and cancer.

• MeSH
• buněčné linie MeSH
• chromozomální aberace MeSH
• down regulace MeSH
• fibroblasty cytologie   metabolismus   MeSH
• fluorescenční mikroskopie MeSH
• fragmentace DNA MeSH
• genový knockout * MeSH
• histony genetika   metabolismus   MeSH
• hybridizace in situ fluorescenční MeSH
• myši MeSH
• poškození DNA MeSH
• protein HMGB1 genetika   metabolismus   MeSH
• protein HMGB2 genetika   metabolismus   MeSH
• replikace DNA MeSH
• RNA genetika   metabolismus   MeSH
• telomerasa genetika   metabolismus   MeSH
• telomery metabolismus   patologie   MeSH
• zvířata MeSH
• Check Tag
• myši MeSH
• zvířata MeSH
• Publikační typ
• časopisecké články MeSH
• práce podpořená grantem MeSH
• Názvy látek
• gamma-H2AX protein, mouse MeSH Prohlížeč
• histony MeSH
• protein HMGB1 MeSH
• protein HMGB2 MeSH
• RNA MeSH
• telomerasa MeSH
• telomerase RNA MeSH Prohlížeč
• Tert protein, mouse MeSH Prohlížeč

A combination of biophysical, biochemical, and computational techniques was used to delineate mechanistic differences between the platinum-acridine hybrid agent [PtCl(en)(L)](NO(3))(2) (complex 1, en = ethane-1,2-diamine, L = 1-[2-(acridin-9-ylamino)ethyl]-1,3-dimethylthiourea) and a considerably more potent second-generation analogue containing L' = N-[2-(acridin-9-ylamino)ethyl]-N-methylpropionamidine (complex 2). Calculations at the density functional theory level provide a rationale for the binding preference of both complexes for guanine-N7 and the relatively high level of adenine adducts observed for compound 1. A significant rate enhancement is observed for binding of the amidine-based complex 2 with DNA compared with the thiourea-based prototype 1. Studies conducted with chemical probes and on the bending and unwinding of model duplex DNA suggest that adducts of complex 2 perturb B-form DNA more severely than complex 1, however, without denaturing the double strand and significantly less than cisplatin. Circular and linear dichroism spectroscopies and viscosity measurements suggest that subtle differences exist between the intercalation modes and adduct geometries of the two complexes. The adducts formed by complex 2 most efficiently inhibit transcription of the damaged DNA by RNA polymerase II. Not only do complexes 1 and 2 cause less distortion to DNA than cisplatin, they also do not compromise the thermodynamic stability of the modified duplex. This leads to a decreased or negligible affinity of HMG domain proteins for the adducts formed by either Pt-acridine complex. In a DNA repair synthesis assay the lesions formed by complex 2 were repaired less efficiently than those formed by complex 1. These significant differences in DNA adduct formation, structure, and recognition between the two acridine complexes and cisplatin help to elucidate why compound 2 is highly active in cisplatin-resistant, repair proficient cancer cell lines.

• MeSH
• adukty DNA chemie   MeSH
• akridiny chemie   metabolismus   farmakologie   MeSH
• amidiny chemie   metabolismus   farmakologie   MeSH
• B-DNA chemie   metabolismus   MeSH
• cisplatina analogy a deriváty   chemie   metabolismus   farmakologie   MeSH
• DNA chemie   metabolismus   MeSH
• genetická transkripce účinky léků   MeSH
• HeLa buňky MeSH
• interkalátory chemie   metabolismus   farmakologie   MeSH
• kinetika MeSH
• konformace nukleové kyseliny účinky léků   MeSH
• lidé MeSH
• oprava DNA účinky léků   MeSH
• organoplatinové sloučeniny chemie   metabolismus   farmakologie   MeSH
• protein - isoformy metabolismus   MeSH
• protein HMGB1 metabolismus   MeSH
• protinádorové látky chemie   metabolismus   farmakologie   MeSH
• racionální návrh léčiv MeSH
• thiomočovina chemie   metabolismus   farmakologie   MeSH
• vztahy mezi strukturou a aktivitou MeSH
• Check Tag
• lidé MeSH
• Publikační typ
• časopisecké články MeSH
• práce podpořená grantem MeSH
• Research Support, N.I.H., Extramural MeSH
• srovnávací studie MeSH
• Názvy látek
• adukty DNA MeSH
• akridiny MeSH
• amidiny MeSH
• B-DNA MeSH
• cisplatina MeSH
• DNA MeSH
• interkalátory MeSH
• organoplatinové sloučeniny MeSH
• protein - isoformy MeSH
• protein HMGB1 MeSH
• protinádorové látky MeSH
• thiomočovina MeSH

Topoisomerase IIalpha (topo IIalpha) is a nuclear enzyme involved in several critical processes, including chromosome replication, segregation and recombination. Previously we have shown that chromosomal protein HMGB1 interacts with topo IIalpha, and stimulates its catalytic activity. Here we show the effect of HMGB1 on the activity of the human topo IIalpha gene promoter in different cell lines. We demonstrate that HMGB1, but not a mutant of HMGB1 incapable of DNA bending, up-regulates the activity of the topo IIalpha promoter in human cells that lack functional retinoblastoma protein pRb. Transient over-expression of pRb in pRb-negative Saos-2 cells inhibits the ability of HMGB1 to activate the topo IIalpha promoter. The involvement of HMGB1 and its close relative, HMGB2, in modulation of activity of the topo IIalpha gene is further supported by knock-down of HMGB1/2, as evidenced by significantly decreased levels of topo IIalpha mRNA and protein. Our experiments suggest a mechanism of up-regulation of cellular expression of topo IIalpha by HMGB1/2 in pRb-negative cells by modulation of binding of transcription factor NF-Y to the topo IIalpha promoter, and the results are discussed in the framework of previously observed pRb-inactivation, and increased levels of HMGB1/2 and topo IIalpha in tumors.

• MeSH
• aktivace transkripce MeSH
• antigeny nádorové biosyntéza   genetika   MeSH
• DNA vazebné proteiny biosyntéza   genetika   MeSH
• DNA-topoisomerasy typu II biosyntéza   genetika   MeSH
• DNA chemie   metabolismus   MeSH
• faktor vázající CCAAT metabolismus   MeSH
• lidé MeSH
• mutageneze MeSH
• nádorové buněčné linie MeSH
• promotorové oblasti (genetika) MeSH
• protein HMGB1 chemie   genetika   metabolismus   MeSH
• protein HMGB2 metabolismus   MeSH
• retinoblastomový protein metabolismus   MeSH
• senioři MeSH
• upregulace * MeSH
• Check Tag
• lidé MeSH
• mužské pohlaví MeSH
• senioři MeSH
• Publikační typ
• časopisecké články MeSH
• práce podpořená grantem MeSH
• Názvy látek
• antigeny nádorové MeSH
• DNA vazebné proteiny MeSH
• DNA-topoisomerasy typu II MeSH
• DNA MeSH
• faktor vázající CCAAT MeSH
• protein HMGB1 MeSH
• protein HMGB2 MeSH
• retinoblastomový protein MeSH

Downstream processes that discriminate between DNA adducts of a third generation platinum antitumor drug oxaliplatin and conventional cisplatin are believed to be responsible for the differences in their biological effects. These different biological effects are explained by the ability of oxaliplatin to form DNA adducts more efficient in their biological effects. In this work conformation, recognition by HMG domain protein and DNA polymerization across the major 1,2-GG intrastrand cross-link formed by cisplatin and oxaliplatin in three sequence contexts were compared with the aid of biophysical and biochemical methods. The following major differences in the properties of the cross-links of oxaliplatin and cisplatin were found: i), the formation of the cross-link by oxaliplatin is more deleterious energetically in all three sequence contexts; ii), the cross-link of oxaliplatin bends DNA slightly but systematically less in all sequence contexts tested; iii), the affinity of HMG domain protein to the cross-link of oxaliplatin is considerably lower independent of the sequence context; and iv), the Klenow fragment of DNA polymerase I pauses considerably more at the cross-link of oxaliplatin in all sequence contexts tested. We have also demonstrated that the chirality at the carrier ligand of oxaliplatin can affect its biological effects.

• MeSH
• adukty DNA chemie   ultrastruktura   MeSH
• guanin chemie   MeSH
• konformace nukleové kyseliny MeSH
• organoplatinové sloučeniny chemie   MeSH
• oxaliplatin MeSH
• párování bází MeSH
• protinádorové látky chemie   MeSH
• reagencia zkříženě vázaná MeSH
• Publikační typ
• časopisecké články MeSH
• práce podpořená grantem MeSH
• Názvy látek
• adukty DNA MeSH
• guanin MeSH
• organoplatinové sloučeniny MeSH
• oxaliplatin MeSH
• protinádorové látky MeSH
• reagencia zkříženě vázaná MeSH

DNA topoisomerase IIalpha (topo IIalpha) is an essential nuclear enzyme and its unique decatenation activity has been implicated in many aspects of chromosome dynamics such as chromosome replication and segregation during mitosis. Here we show that chromatin-associated protein HMGB1 (a member of the large family of HMG-box proteins with possible functions in DNA replication, transcription, recombination and DNA repair) promotes topo IIalpha-mediated catenation of circular DNA, relaxation of negatively supercoiled DNA and decatenation of kinetoplast DNA. HMGB1 interacts with topo IIalpha and this interaction, like the stimulation of the catalytic activity of the enzyme, requires both HMG-box domains of HMGB1. A mutant of HMGB1, which cannot change DNA topology stimulates DNA decatenation by topo IIalpha indistinguishably from the wild-type protein. Although HMGB1 stimulates ATP hydrolysis by topo IIalpha, the DNA cleavage is much more enhanced. The observed abilities of HMGB1 to interact with topo IIalpha and promote topo IIalpha binding to DNA suggest a mechanism by which HMGB1 stimulates the catalytic activity of the enzyme via enhancement of DNA cleavage.

• MeSH
• adenosintrifosfát metabolismus   MeSH
• antigeny nádorové metabolismus   MeSH
• diketopiperaziny MeSH
• DNA vazebné proteiny metabolismus   MeSH
• DNA-topoisomerasy typu II metabolismus   MeSH
• DNA chemie   metabolismus   ultrastruktura   MeSH
• elektroforéza v agarovém gelu MeSH
• inhibitory enzymů farmakologie   MeSH
• katalýza MeSH
• kinetoplastová DNA metabolismus   MeSH
• konformace nukleové kyseliny MeSH
• kruhová DNA metabolismus   MeSH
• krysa rodu Rattus MeSH
• lidé MeSH
• piperaziny farmakologie   MeSH
• protein HMGB1 MeSH
• proteiny s vysokou pohyblivostí metabolismus   MeSH
• represorové proteiny metabolismus   MeSH
• superhelikální DNA metabolismus   MeSH
• zvířata MeSH
• Check Tag
• krysa rodu Rattus MeSH
• lidé MeSH
• zvířata MeSH
• Publikační typ
• časopisecké články MeSH
• práce podpořená grantem MeSH
• Názvy látek
• 4,4'-(1,2-dimethyl-1,2-ethanediyl)bis-2,6-piperazinedione MeSH Prohlížeč
• adenosintrifosfát MeSH
• antigeny nádorové MeSH
• diketopiperaziny MeSH
• DNA vazebné proteiny MeSH
• DNA-topoisomerasy typu II MeSH
• DNA MeSH
• Hbp1 protein, rat MeSH Prohlížeč
• inhibitory enzymů MeSH
• kinetoplastová DNA MeSH
• kruhová DNA MeSH
• piperaziny MeSH
• protein HMGB1 MeSH
• proteiny s vysokou pohyblivostí MeSH
• represorové proteiny MeSH
• superhelikální DNA MeSH

The structure-pharmacological activity relationships generally accepted for antitumor platinum compounds stressed the necessity for the cis-[PtX(2)(amine)(2)] structure while the trans-[PtX(2)(amine)(2)] structure was considered inactive. However, more recently, several trans-platinum complexes have been identified which are potently toxic, antitumor-active and demonstrate activity distinct from that of conventional cisplatin (cis-[PtCl(2)(NH(3))(2)]). We have shown in the previous report that the replacement of ammine ligands by iminoether in transplatin (trans-[PtCl(2)(NH(3))(2)]) results in a marked enhancement of its cytotoxicity so that it is more cytotoxic than its cis congener and exhibits significant antitumor activity, including activity in cisplatin-resistant tumor cells. In addition, we have also shown previously that this new trans compound (trans-[PtCl(2)(E-iminoether)(2)]) forms mainly monofunctional adducts at guanine residues on DNA, which is generally accepted to be the cellular target of platinum drugs. In order to shed light on the mechanism underlying the antitumor activity of trans-[PtCl(2)(E-iminoether)(2)] we examined oligodeoxyribonucleotide duplexes containing a single, site-specific, monofunctional adduct of this transplatin analog by the methods of molecular biophysics. The results indicate that major monofunctional adducts of trans-[PtCl(2)(E-iminoether)(2)] locally distort DNA, bend the DNA axis by 21 degrees toward the minor groove, are not recognized by HMGB1 proteins and are readily removed from DNA by nucleotide excision repair (NER). In addition, the monofunctional adducts of trans-[PtCl(2)(E-iminoether)(2)] readily cross-link proteins, which markedly enhances the efficiency of this adduct to terminate DNA polymerization by DNA polymerases in vitro and to inhibit removal of this adduct from DNA by NER. It is suggested that DNA-protein ternary cross-links produced by trans-[PtCl(2)(E-iminoether)(2)] could persist considerably longer than the non-cross-linked monofunctional adducts, which would potentiate toxicity of this antitumor platinum compound toward tumor cells sensitive to this drug. Thus, trans-[PtCl(2)(E-iminoether)(2)] represents a quite new class of platinum antitumor drugs in which activation of trans geometry is associated with an increased efficiency to form DNA-protein ternary cross-links thereby acting by a different mechanism from 'classical' cisplatin and its analogs.

• MeSH
• adukty DNA chemie   metabolismus   MeSH
• CHO buňky MeSH
• cisplatina analogy a deriváty   chemie   farmakologie   MeSH
• DNA-dependentní DNA-polymerasy metabolismus   MeSH
• DNA chemie   účinky léků   metabolismus   MeSH
• domény HMG-Box MeSH
• HeLa buňky MeSH
• konformace nukleové kyseliny účinky léků   MeSH
• křečci praví MeSH
• krysa rodu Rattus MeSH
• lidé MeSH
• makromolekulární látky MeSH
• oligonukleotidy chemie   metabolismus   MeSH
• protein HMGB1 chemie   metabolismus   MeSH
• reagencia zkříženě vázaná chemie   farmakologie   MeSH
• vazba proteinů MeSH
• vazebná místa MeSH
• zvířata MeSH
• Check Tag
• křečci praví MeSH
• krysa rodu Rattus MeSH
• lidé MeSH
• zvířata MeSH
• Publikační typ
• časopisecké články MeSH
• práce podpořená grantem MeSH
• Názvy látek
• adukty DNA MeSH
• cisplatina MeSH
• DNA-dependentní DNA-polymerasy MeSH
• DNA MeSH
• makromolekulární látky MeSH
• oligonukleotidy MeSH
• protein HMGB1 MeSH
• reagencia zkříženě vázaná MeSH